Impact of fluoxetine exposure on Lymnaea stagnalis and its developing eggs: integrating untargeted lipidomics, targeted metabolomics, and classical risk assessment

Pharmaceuticals such as selective serotonin reuptake inhibitors (SSRIs), are increasingly detected in aquatic environments, posing potential risks to non-target organisms, because many of those substances are widely shared neuromodulator. In this study, we investigated the effects of SSRI antidepres...

Full description

Saved in:
Bibliographic Details
Main Authors: Diana Ilyaskina, Yumi Nakadera, Marja H. Lamoree, Joris M. Koene, Pim E. G. Leonards
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-02-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2025.1536438/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832542314716725248
author Diana Ilyaskina
Yumi Nakadera
Yumi Nakadera
Marja H. Lamoree
Joris M. Koene
Pim E. G. Leonards
author_facet Diana Ilyaskina
Yumi Nakadera
Yumi Nakadera
Marja H. Lamoree
Joris M. Koene
Pim E. G. Leonards
author_sort Diana Ilyaskina
collection DOAJ
description Pharmaceuticals such as selective serotonin reuptake inhibitors (SSRIs), are increasingly detected in aquatic environments, posing potential risks to non-target organisms, because many of those substances are widely shared neuromodulator. In this study, we investigated the effects of SSRI antidepressant, namely, fluoxetine, exposure on the freshwater snail L. stagnalis, focusing on egg development, neurochemical pathways, and lipid metabolism. Snails were exposed to a range of 51–434 µg fluoxetine L⁻1 for 7 days, followed by analysis of survival, feeding behaviour, reproduction, and metabolomic changes in the central nervous system (CNS), albumen gland, and eggs. Although no significant effects were observed on survival or fecundity, fluoxetine exposure significantly impaired egg development in a dose-dependent manner, reducing hatching rates with an EC50 of 126 µg fluoxetine L⁻1. Removal of eggs from the contaminated environment partially reversed these developmental effects, suggesting potential recovery if fluoxetine levels decrease. Molecular analysis revealed several neurochemical and lipidomic alterations. In the CNS, elevated levels of catecholamines, phosphatidylcholines (PC), and ceramides were linked to disruptions in neurotransmission, membrane integrity, and impaired embryo development. In the albumen gland, we detected a decrease of key lipid classes, including sphingomyelins and fatty acids, which can be linked with impaired egg quality. Additionally, a decrease in histamine in both the albumen gland and eggs suggested further disruption of egg development, potentially affecting metamorphosis success. Moreover, the dose-dependent increase in choline, along with PC and oxidized PC, indicated oxidative stress and lipid peroxidation in the CNS and exposed eggs of Lymnaea stagnalis. Our findings highlight the benefits of combining behavioral assessments with metabolomic profiling to better understand the mechanistic pathways underlying fluoxetine’s adverse effects.
format Article
id doaj-art-7cd5656d94474d7da61c0fbde0e50ad5
institution Kabale University
issn 1663-9812
language English
publishDate 2025-02-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pharmacology
spelling doaj-art-7cd5656d94474d7da61c0fbde0e50ad52025-02-04T06:31:53ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122025-02-011610.3389/fphar.2025.15364381536438Impact of fluoxetine exposure on Lymnaea stagnalis and its developing eggs: integrating untargeted lipidomics, targeted metabolomics, and classical risk assessmentDiana Ilyaskina0Yumi Nakadera1Yumi Nakadera2Marja H. Lamoree3Joris M. Koene4Pim E. G. Leonards5Amsterdam Institute for Life and Environment (A-LIFE), Vrije Universiteit Amsterdam, Amsterdam, NetherlandsAmsterdam Institute for Life and Environment (A-LIFE), Vrije Universiteit Amsterdam, Amsterdam, NetherlandsSenckenberg Ocean Species Alliance, Senckenberg Research Institute and Natural History Museum Frankfurt, Frankfurt, GermanyAmsterdam Institute for Life and Environment (A-LIFE), Vrije Universiteit Amsterdam, Amsterdam, NetherlandsAmsterdam Institute for Life and Environment (A-LIFE), Vrije Universiteit Amsterdam, Amsterdam, NetherlandsAmsterdam Institute for Life and Environment (A-LIFE), Vrije Universiteit Amsterdam, Amsterdam, NetherlandsPharmaceuticals such as selective serotonin reuptake inhibitors (SSRIs), are increasingly detected in aquatic environments, posing potential risks to non-target organisms, because many of those substances are widely shared neuromodulator. In this study, we investigated the effects of SSRI antidepressant, namely, fluoxetine, exposure on the freshwater snail L. stagnalis, focusing on egg development, neurochemical pathways, and lipid metabolism. Snails were exposed to a range of 51–434 µg fluoxetine L⁻1 for 7 days, followed by analysis of survival, feeding behaviour, reproduction, and metabolomic changes in the central nervous system (CNS), albumen gland, and eggs. Although no significant effects were observed on survival or fecundity, fluoxetine exposure significantly impaired egg development in a dose-dependent manner, reducing hatching rates with an EC50 of 126 µg fluoxetine L⁻1. Removal of eggs from the contaminated environment partially reversed these developmental effects, suggesting potential recovery if fluoxetine levels decrease. Molecular analysis revealed several neurochemical and lipidomic alterations. In the CNS, elevated levels of catecholamines, phosphatidylcholines (PC), and ceramides were linked to disruptions in neurotransmission, membrane integrity, and impaired embryo development. In the albumen gland, we detected a decrease of key lipid classes, including sphingomyelins and fatty acids, which can be linked with impaired egg quality. Additionally, a decrease in histamine in both the albumen gland and eggs suggested further disruption of egg development, potentially affecting metamorphosis success. Moreover, the dose-dependent increase in choline, along with PC and oxidized PC, indicated oxidative stress and lipid peroxidation in the CNS and exposed eggs of Lymnaea stagnalis. Our findings highlight the benefits of combining behavioral assessments with metabolomic profiling to better understand the mechanistic pathways underlying fluoxetine’s adverse effects.https://www.frontiersin.org/articles/10.3389/fphar.2025.1536438/fullfluoxetineLymnaea stagnalislipid metabolismecotoxicologyneurochemical pathways
spellingShingle Diana Ilyaskina
Yumi Nakadera
Yumi Nakadera
Marja H. Lamoree
Joris M. Koene
Pim E. G. Leonards
Impact of fluoxetine exposure on Lymnaea stagnalis and its developing eggs: integrating untargeted lipidomics, targeted metabolomics, and classical risk assessment
Frontiers in Pharmacology
fluoxetine
Lymnaea stagnalis
lipid metabolism
ecotoxicology
neurochemical pathways
title Impact of fluoxetine exposure on Lymnaea stagnalis and its developing eggs: integrating untargeted lipidomics, targeted metabolomics, and classical risk assessment
title_full Impact of fluoxetine exposure on Lymnaea stagnalis and its developing eggs: integrating untargeted lipidomics, targeted metabolomics, and classical risk assessment
title_fullStr Impact of fluoxetine exposure on Lymnaea stagnalis and its developing eggs: integrating untargeted lipidomics, targeted metabolomics, and classical risk assessment
title_full_unstemmed Impact of fluoxetine exposure on Lymnaea stagnalis and its developing eggs: integrating untargeted lipidomics, targeted metabolomics, and classical risk assessment
title_short Impact of fluoxetine exposure on Lymnaea stagnalis and its developing eggs: integrating untargeted lipidomics, targeted metabolomics, and classical risk assessment
title_sort impact of fluoxetine exposure on lymnaea stagnalis and its developing eggs integrating untargeted lipidomics targeted metabolomics and classical risk assessment
topic fluoxetine
Lymnaea stagnalis
lipid metabolism
ecotoxicology
neurochemical pathways
url https://www.frontiersin.org/articles/10.3389/fphar.2025.1536438/full
work_keys_str_mv AT dianailyaskina impactoffluoxetineexposureonlymnaeastagnalisanditsdevelopingeggsintegratinguntargetedlipidomicstargetedmetabolomicsandclassicalriskassessment
AT yuminakadera impactoffluoxetineexposureonlymnaeastagnalisanditsdevelopingeggsintegratinguntargetedlipidomicstargetedmetabolomicsandclassicalriskassessment
AT yuminakadera impactoffluoxetineexposureonlymnaeastagnalisanditsdevelopingeggsintegratinguntargetedlipidomicstargetedmetabolomicsandclassicalriskassessment
AT marjahlamoree impactoffluoxetineexposureonlymnaeastagnalisanditsdevelopingeggsintegratinguntargetedlipidomicstargetedmetabolomicsandclassicalriskassessment
AT jorismkoene impactoffluoxetineexposureonlymnaeastagnalisanditsdevelopingeggsintegratinguntargetedlipidomicstargetedmetabolomicsandclassicalriskassessment
AT pimegleonards impactoffluoxetineexposureonlymnaeastagnalisanditsdevelopingeggsintegratinguntargetedlipidomicstargetedmetabolomicsandclassicalriskassessment